These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 338297)

  • 1. Effects of alterations in the metabolism of gamma-aminobutyrate on convulsant potencies.
    Stone WE
    Epilepsia; 1977 Dec; 18(4):507-15. PubMed ID: 338297
    [No Abstract]   [Full Text] [Related]  

  • 2. The anticonvulsant action of GABA-elevating agents: a re-evaluation.
    Wood JD; Peesker SJ
    J Neurochem; 1975 Sep; 25(3):277-82. PubMed ID: 1159424
    [No Abstract]   [Full Text] [Related]  

  • 3. Modification of pp' DDT induced convulsions by changes in the level of cerebral gamma-aminobutyric acid in mice.
    Matin MA; Kar PP; Anand M
    J Neurochem; 1976 Oct; 27(4):979-81. PubMed ID: 966034
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of chronic treatment with amino-oxyacetic acid or sodium n-dipropylacetate on brain GABA levels and the development and regression of cobalt epileptic foci in rats.
    Emson PC
    J Neurochem; 1976 Dec; 27(6):1489-94. PubMed ID: 794443
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of drug-induced increase of brain GABA levels on penicillin focus.
    Elazar Z; Gottesfeld Z
    Experientia; 1975 Jun; 31(6):676-8. PubMed ID: 1095391
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological investigation of convulsant gamma-aminobutyric acid (GABA) antagonists in amygdala-kindled rats.
    Kalichman MW
    Epilepsia; 1982 Apr; 23(2):163-71. PubMed ID: 7075571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gamma-Aminobutyric acid metabolism in subcellular particles of mouse brain and its relationship to convulsions.
    Abe M; Matsuda M
    J Biochem; 1977 Jul; 82(1):195-200. PubMed ID: 893380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the amino acid content of nerve endings (synaptosomes) induced by drugs that alter the metabolism of glutamate and gamma-aminobutyric acid.
    Geddes JW; Wood JD
    J Neurochem; 1984 Jan; 42(1):16-24. PubMed ID: 6139419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of synaptosomal GABA levels and their use in determining the in vivo effects of drugs: convulsant agents.
    Wood JD; Russell MP; Kurylo E; Newstead JD
    J Neurochem; 1979 Jul; 33(1):61-8. PubMed ID: 458472
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of gamma-aminobutyric acid (GABA) in mice with audiogenic seizures.
    Anlezark G; Horton RW; Meldrium BS; Sawaya CB
    Biochem Pharmacol; 1976 Feb; 25(4):413-7. PubMed ID: 779794
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticonvulsant activity of aminooxyacetic acid on convulsions induced by thiosemicarbazide.
    Murakami Y; Abe M; Murakami K
    J Neurochem; 1976 Mar; 26(3):655-6. PubMed ID: 1262886
    [No Abstract]   [Full Text] [Related]  

  • 12. Aminooxyacetic acid induced changes in gamma-aminobutyrate metabolism at the subcellular level.
    Wood JD; Kurylo E; Newstead JD
    Can J Biochem; 1978 Jun; 56(6):667-72. PubMed ID: 667703
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-mortem and aminooxyacetic acid-induced accumulation of GABA: effect of gamma-butyrolactone and picrotoxin.
    Pericić D; Eng N; Walters JR
    J Neurochem; 1978 Apr; 30(4):767-73. PubMed ID: 650217
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical effects in man and rat of three drugs which can increase brain GABA content.
    Perry TL; Hansen S
    J Neurochem; 1978 Apr; 30(4):679-84. PubMed ID: 148494
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of an expression which relates the excitable state of the brain to the level of GAD activity and GABA content, with particular reference to the action of hydrazine and its derivatives.
    Wood JD; Peesker SJ
    J Neurochem; 1974 Oct; 23(4):703-12. PubMed ID: 4154354
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between gamma-aminobutyric acid metabolism and antivitamin B6-induced convulsions.
    Abe M
    J Nutr Sci Vitaminol (Tokyo); 1978; 24(4):419-27. PubMed ID: 712435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring changes in cerebral glutamate and GABA metabolism prior to convulsions induced by 3-mercaptopropionate.
    Adcock T; Taberner PV
    Biochem Pharmacol; 1978 Jan; 27(2):246-8. PubMed ID: 623679
    [No Abstract]   [Full Text] [Related]  

  • 18. Epilepsy and gamma-aminobutyric acid-mediated inhibition.
    Meldrum BS
    Int Rev Neurobiol; 1975; 17():1-36. PubMed ID: 166954
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuronal and glial systems for gamma-aminobutyric acid transport.
    Sellström A; Hamberger A
    J Neurochem; 1975 May; 24(5):847-52. PubMed ID: 167125
    [No Abstract]   [Full Text] [Related]  

  • 20. 3-Mercaptopropionic acid: convulsant properties, effects on enzymes of the gamma-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, aminooxyacetic acid and gabaculine.
    Löscher W
    Biochem Pharmacol; 1979 Apr; 28(8):1397-407. PubMed ID: 444305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.